The global Biosimilars Market, valued at US$32.75 billion in 2024 stood at US$35.04 billion in 2025 and is projected to advance at a resilient ...

The global Biosimilars Market, valued at US$32.75 billion in 2024 stood at US$35.04 billion in 2025 and is projected to ...

Swiss generic-drug maker Sandoz Group AG sharply criticized a recent appeal by Europe’s pharmaceutical industry urging the European Union to increase drug prices as a way to counter the threat of US ...

PHARMA ROUNDTABLE — The FDA hosts its first ... when asked about the closing of the appeal window. NEW BIOSIMILARS — Sandoz, a global maker of generic and biosimilar medicines, announced ...

DUBLIN, June 2, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced long-term data, including the first report of median overall survival (OS) from the Phase 2 trial ...

- The FDA grants Priority Review designation for the evaluation of medicines that, if approved, would provide a significant improvement in the safety or effectiveness of the treatment, prevention, or ...

MUMBAI, India and PRINCETON, N.J., May 30, 2025 /PRNewswire/ -- Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE ...

I am eager to be a part of these exciting times at Sandoz —supporting our evolution as a standalone organization, enabling future-ready capabilities, and helping bring our People & Organization ...

The Company reported advancing its efforts to strengthen the protection of its intellectual property across additional Asian markets, following the recently granted patent in India for a ...